Blog
Health Canada Compliance Insights
NHPD testing guides, Canadian regulatory updates, and compliance insights for natural health product manufacturers, supplement brands, and Amazon Canada sellers.
What a Certificate of Analysis Must Include Under Canadian GMP: A Manufacturer's Checklist
A complete breakdown of the 12 required elements for a compliant certificate of analysis under Health Canada GMP — and where most manufacturers fall short.
Selecting a CRO in Canada: A Practical Evaluation Framework for Pharmaceutical Companies
How to evaluate a contract research organization in Canada — key criteria, Health Canada GMP requirements, red flags, and qualification steps for pharma teams.
Good Distribution Practices Under Canada GMP: What Pharmaceutical Distributors Need to Know
Health Canada's GMP framework extends well beyond the manufacturing floor. Learn what Canadian pharmaceutical distributors must do to meet GDP compliance.
Biosimilar Drug Development in Canada: What Health Canada's Approval Framework Actually Requires
Health Canada biosimilar approval: what the NDS pathway requires in comparative analytics, GMP compliance, and clinical evidence for Canadian sponsors.
How to Conduct a GMP Gap Analysis Before Your Health Canada Inspection
A practical framework for pharmaceutical manufacturers to assess Health Canada GMP compliance gaps before inspection — covering documentation, CAPA, lab controls, and validation.
Vendor Qualification Under Canada GMP: What Health Canada Inspectors Expect From Your Supplier Program
Build a Health Canada GMP-compliant vendor qualification program: risk tiers, audit frequency, approved supplier lists, and what inspectors actually check.
API Impurity Profiling for Canadian Drug Submissions: What Health Canada Reviewers Actually Expect
ICH Q3A(R2) sets the impurity profiling standard for Canadian drug submissions. Here's what Health Canada reviewers look for — and where sponsors fall short.
NPN Applications in Canada: Why Deficiency Notices Happen — and How to Submit Right the First Time
Most NPN rejections in Canada are preventable. Learn the common deficiency notice triggers under natural health products regulations and how to avoid them.
Change Control Under Health Canada GMP Guidelines: A Practical Framework for Canadian Manufacturers
Learn how to build a change control system that satisfies Health Canada GMP guidelines — covering classification, documentation, and NHPR site licence obligations.
Selecting a Contract Research Organization in Canada: What Pharma Sponsors Actually Need to Evaluate
Not all Canadian CROs are equal. Learn five criteria pharma sponsors must check before outsourcing to a contract research organization in Canada.
Dissolution Testing for Canadian Generic Drug Submissions: What Health Canada Reviewers Actually Check
What Health Canada reviewers look for in ANDS dissolution packages — f2 criteria, BCS biowaivers, and the data deficiencies that delay DIN approval.
Post-Market Pharmacovigilance in Canada: What Your CRO or CMO Is Actually Responsible For
Health Canada pharmacovigilance obligations for Canadian CROs and CMOs: 15-day ADR reporting, PSUR requirements, and what Vanessa's Law changed.
ANDS in Canada: Bioequivalence Requirements, the Canadian Reference Product Rule, and Common Submission Pitfalls
Planning an Abbreviated New Drug Submission in Canada? Learn Health Canada's bioequivalence requirements, the Canadian Reference Product rule, and the most common ANDS pitfalls.
Orphan Drug Designation in Canada: What Rare Disease Sponsors Need to Know Before Filing with Health Canada
Canada has no Orphan Drug Act — but rare disease sponsors have real pathways. Learn how Priority Review, NOC/c, and Project Orbis work under Health Canada.
Why Your NPN Application Gets Rejected — And How to Fix It Before Submission
Health Canada NPN applications fail for predictable reasons. Learn the five most common rejection causes and what to fix before you file your NHPD submission.
Impurity Profiling in API Development: What Health Canada's ICH Q3A Requirements Actually Demand
How Health Canada applies ICH Q3A and Q3D impurity guidelines in practice — thresholds, genotoxic limits, and what a defensible Canadian NDS package requires.
NPN Application Requirements: Why Health Canada Issues a Notice of Deficiency (And How to Avoid It)
Learn why NPN applications receive a Notice of Deficiency from Health Canada and how to address evidence, labelling, quality, and site licence gaps before you submit.
Product Licence Amendments: When and How to Update Your NPN with Health Canada
A practical guide to Health Canada's NPN product licence amendment requirements: when to file, what to include, and how to plan around 210-day timelines.